Abiopharma

JCDecaux : Déclaration des transactions sur actions propres

General Announcement: Next Day Disclosure Return

NEURONES: Declaration of transactions on treasury shares (June 8 to 12, 2026)

NEURONES : Déclaration des transactions sur actions propres (période du 8 au 12 juin 2026)

Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy

Warrants - Change of Terms: Notice of Change of Terms

Correction: Ekstraordinære indfrielser (CK 93)

Ekstraordinære indfrielser (CK 93)

Net Asset Value(s)

RBLX Investors Have Opportunity to Lead Roblox Corporation Securities Fraud Lawsuit with the Schall Law Firm